These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 6503214)
41. The use of transdermal clonidine in the hypertensive patient with chronic renal failure. Lowenthal DT; Saris SD; Paran E; Cristal N Clin Nephrol; 1993 Jan; 39(1):37-43. PubMed ID: 8428406 [TBL] [Abstract][Full Text] [Related]
42. Transdermal and oral clonidine. Lilja M; Juustila H; Sarna S; Jounela AJ Ann Med; 1991 Aug; 23(3):265-9. PubMed ID: 1930916 [TBL] [Abstract][Full Text] [Related]
43. Allergic contact dermatitis from a clonidine transdermal delivery system. Corazza M; Mantovani L; Virgili A; Strumia R Contact Dermatitis; 1995 Apr; 32(4):246. PubMed ID: 7600788 [No Abstract] [Full Text] [Related]
46. Bioequivalence and adhesion evaluation of transdermal clonidine following a change in excipient supplier. Ehrlich J; Beck B; Thiedmann R; Marzin K; MacGregor T Int J Clin Pharmacol Ther; 2016 Oct; 54(10):816-24. PubMed ID: 27390050 [TBL] [Abstract][Full Text] [Related]
47. Skin pretreatment and the use of transdermal clonidine. Ito MK; O'Connor DT Am J Med; 1991 Jul; 91(1A):42S-49S. PubMed ID: 1831005 [TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetics and pharmacodynamics of transdermally administered clonidine. Arndts D; Arndts K Eur J Clin Pharmacol; 1984; 26(1):79-85. PubMed ID: 6714294 [TBL] [Abstract][Full Text] [Related]
49. Skin acceptance of transcutaneous nitroglycerin patches: a prospective study of 33 patients. Vaillant L; Biette S; Machet L; Constans T; Monpère C Contact Dermatitis; 1990 Sep; 23(3):142-5. PubMed ID: 2126502 [TBL] [Abstract][Full Text] [Related]
52. [Transdermal clonidine: a new therapeutic approach in essential hypertension?]. Groth H; Greminger P; Vetter H; Knüsel J; Baumgart P; Siegenthaler W; Vetter W Schweiz Rundsch Med Prax; 1985 Mar; 74(11):265-9. PubMed ID: 3158058 [No Abstract] [Full Text] [Related]
53. Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route. Shaw JE Am Heart J; 1984 Jul; 108(1):217-23. PubMed ID: 6428208 [TBL] [Abstract][Full Text] [Related]
54. Transdermal clonidine for hypertension. Med Lett Drugs Ther; 1985 Oct; 27(700):95-6. PubMed ID: 4058369 [No Abstract] [Full Text] [Related]
55. Use of transdermal clonidine in chronic hemodialysis patients. Rosansky SJ; Johnson KL; McConnell J Clin Nephrol; 1993 Jan; 39(1):32-6. PubMed ID: 8428405 [TBL] [Abstract][Full Text] [Related]
56. Allergic contact dermatitis from transdermal clonidine in a patient with mycosis fungoides. Polster AM; Warner MR; Camisa C Cutis; 1999 Mar; 63(3):154-5. PubMed ID: 10190065 [TBL] [Abstract][Full Text] [Related]
57. Transdermal antihypertensive therapy: clinical and metabolic considerations. Weber MA Am Heart J; 1986 Oct; 112(4):906-12. PubMed ID: 2945415 [TBL] [Abstract][Full Text] [Related]
58. Rebound hypertension during initiation of transdermal clonidine. Stewart M; Burris JF Drug Intell Clin Pharm; 1988; 22(7-8):573-4. PubMed ID: 3416742 [TBL] [Abstract][Full Text] [Related]
59. Therapeutic adherence in the elderly: transdermal clonidine compared to oral verapamil for hypertension. Burris JF; Papademetriou V; Wallin JD; Cook ME; Weidler DJ Am J Med; 1991 Jul; 91(1A):22S-28S. PubMed ID: 1867225 [TBL] [Abstract][Full Text] [Related]
60. Transdermal clonidine as an adjunct to nifedipine-GITS therapy in patients with mild-to-moderate hypertension. Houston MC; Hays L Am Heart J; 1993 Oct; 126(4):918-23. PubMed ID: 8213450 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]